The DASS-167 has demonstrated excellent psychometric properties, including:
DASS-167 has demonstrated potent inhibitory activity against the SARS-CoV-2 virus in various in vitro and in vivo models. In a viral replication assay, DASS-167 showed a half-maximal effective concentration (EC50) of 0.12 μM, indicating its high potency against the virus. Additionally, the compound has been shown to exhibit synergistic activity when combined with other antiviral agents, such as remdesivir. DASS-167
The DASS-167 has demonstrated good psychometric properties in various studies. Some of the key findings include: DASS-167